Jafra Capital Management’s Pfizer PFE Stock Holding History

Jafra Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-42,160	Closed	-$1.42M	–	106
2018 Q1	$1.42M	Buy	+42,160	New	+$1.45M	0.44%	62
2017 Q2	–	Sell	-132,567	Closed	-$4.3M	–	85
2017 Q1	$4.3M	Buy	+132,567	New	+$4.18M	1.73%	22

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jafra Capital Management's PFE Position: Q2 2018 in Review

Jafra Capital Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 42,160 shares — an estimated $1.42M sold.

Jafra Capital Management first reported a position in PFE in Q1 2017 and held it in 2 quarters. The position peaked at $4.3M in Q1 2017. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Jafra Capital Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Jafra Capital Management sold 42,160 Pfizer shares in Q2 2018, an estimated $1.42M.
Jafra Capital Management first reported a position in Pfizer in Q1 2017 and held it in 2 quarters.
Jafra Capital Management's Pfizer position peaked at $4.3M in Q1 2017.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Jafra Capital Management's 13F filing for Q2 2018, filed 15 Aug 2018.